All Stories

  1. Preeclampsia and platelets activation
  2. Gastric cancer in Latin America
  3. Letter: proton pump inhibitors and the risk of hepatocellular carcinoma
  4. Aetiology of hepatocellular carcinoma in South America
  5. Letter: the risk of cancer in patients with gastric intestinal metaplasia
  6. Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy
  7. Alpha1-antitrypsin deficiency and c-JUN
  8. Application of proteomics to the study of Helicobacter pylori and implications for the clinic
  9. Anti-phospholipid syndrome therapy
  10. Letter: years of life that could be saved by preventing HCC
  11. Antiphospholipid syndrome, preeclampsia, and infection byHelicobacter pylori
  12. Risk factors for hepatocellular carcinoma
  13. High hepatocellular carcinoma risk among US-born Hispanics
  14. Preeclampsia relates to H.pylori
  15. Constructal approach to bio-engineering: the ocular anterior chamber temperature
  16. Hepatitis C virus and lymphoma
  17. Thermodynamic considerations on Ca2+-induced biochemical reactions in living cells
  18. Constructal approach to cell membranes transport: Amending the ‘Norton-Simon’ hypothesis for cancer treatment
  19. The Extraordinary Progress in Very Early Cancer Diagnosis and Personalized Therapy: The Role of Oncomarkers and Nanotechnology
  20. A thermodynamic approach to the ‘mitosis/apoptosis’ ratio in cancer
  21. Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets
  22. A thermo-physical analysis of the proton pump vacuolar-ATPase: the constructal approach
  23. Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials
  24. Magnetic fields encountered in electric transport: Rail systems, trolleybus and cars
  25. Analysis of magnetic fields onboard electric transport systems in regard to human exposure
  26. Liver Stem Cells and Possible Clinical Applications
  27. Microparticles in physiological and in pathological conditions
  28. Helicobacter pyloriiseroprevalence in hepatitis C virus positive patients with cirrhosis
  29. Long term follow-up after H.pylori eradication: Results of a prospective study
  30. Patients with hepatocellular carcinoma have a high prevalence of antibodies to Helicobacter pylori
  31. Helicobacter pylori infection and extradigestive diseases
  32. Helicobacter pylori infection and extradigestive diseases
  33. Helicobacter pylori screening and gastric cancer
  34. Role of hepatitis delta virus infection in hepatocellular carcinoma
  35. Transfusion-Related Delta Hepatitis
  36. Serological diagnosis of acute viral hepatitis
  37. Ribosome biosynthesis in Escherichia coli. Limiting step